A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Clinical trial NCT05708950 · COMPLETED

Trial details

NCT number: NCT05708950
Sponsor: Kineta Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Solid Tumor Melanoma Carcinoma Sarcoma Lung Cancer Prostate Cancer Breast Cancer Colo-rectal Cancer Uterine Cancer Pancreatic Cancer Gastric Cancer

Start date: 2023-03-03
Primary completion: 2025-10-16
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.